Tatiana Marie Grzeszkiewicz, MD
Dermatology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
10 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Grzeszkiewicz’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A88967 · Current
Licensed to practise in California · since 2004 · expires 2028-07-31 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$195,529
Medicare paid this office $195,529 for 849 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 371 | $46,997 | $101 |
| Short return visit (20+ min) | 345 | $30,804 | $72 |
| New patient visit (45+ min) | 117 | $15,290 | $131 |
| Application of ultraviolet light to skin | 19 | $11,577 | $25 |
| Destruction of skin growth, 1-14 growths | 92 | $10,721 | $104 |
See all 17 services
| Return visit (30+ min) | 371 | $46,997 | $101 |
| Short return visit (20+ min) | 345 | $30,804 | $72 |
| New patient visit (45+ min) | 117 | $15,290 | $131 |
| Application of ultraviolet light to skin | 19 | $11,577 | $25 |
| Destruction of skin growth, 1-14 growths | 92 | $10,721 | $104 |
| Biopsy of related skin growth, first growth | 91 | $9,663 | $93 |
| Application of light by qualified health care professional to destroy precancer skin growth | 21 | $8,944 | $229 |
| Destruction of precancer skin growth, 15 or more growths | 45 | $8,784 | $160 |
| New patient visit (30+ min) | 100 | $7,989 | $80 |
| Destruction of precancer skin growth, 1 growth | 125 | $7,148 | $49 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 11 | $5,508 | None |
| Destruction of precancer skin growth, 2-14 growths | 99 | $4,120 | $7 |
| Punch biopsy, first skin growth | 14 | $1,669 | $119 |
| Short return visit | 28 | $1,517 | $46 |
| Biopsy of related skin growth, each additional growth | 15 | $1,022 | $49 |
| New patient visit (15+ min) | 17 | $792 | $47 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 21 | $319 | $14 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 12 | More than 66% of doctors who do this |
| Removal of skin lesions | 540 | More than 87% of doctors who do this |
| Removal or shaving of skin growth | 24 | More than 73% of doctors who do this |
| Skin biopsy | 160 | More than 82% of doctors who do this |
Who their Medicare patients are
849 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 10% · Women 55% · Also on Medicaid 10% · Health risk score 0.93. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 58% · Coronary heart disease 20% · Diabetes 18% · Chronic kidney disease 16% · Depression 14% · Cancer 13% · Atrial fibrillation 13% · Heart failure 10% · COPD 6% · Dementia 4% · Stroke 3%.
The office billed $760,812, Medicare allowed $273,989 and paid $195,529; for 2,962 services of 45 kinds; $5,511 of it was for drugs given in the office and $190,017 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 849 | 2,962 | 74 | 0.93 | $760,812 | $195,529 |
| 2023 | 838 | 3,068 | 74 | 0.93 | $806,898 | $215,101 |
| 2022 | 933 | 3,520 | 74 | 0.94 | $925,026 | $248,405 |
| 2021 | 801 | 3,290 | 74 | 0.92 | $883,053 | $256,215 |
| 2020 | 593 | 2,771 | 74 | 0.97 | $741,856 | $206,116 |
| 2019 | 685 | 3,301 | 74 | 1.11 | $867,343 | $236,768 |
| 2018 | 605 | 3,256 | 74 | 1.14 | $787,159 | $201,271 |
| 2017 | 601 | 2,987 | 74 | 1.20 | $780,170 | $197,460 |
| 2016 | 526 | 3,031 | 74 | 1.02 | $784,948 | $201,190 |
| 2015 | 548 | 2,949 | 73 | 1.04 | $774,894 | $213,007 |
| 2014 | 498 | 2,399 | 73 | 1.02 | $496,886 | $142,425 |
| 2013 | 435 | 2,148 | 73 | 0.99 | $457,310 | $123,147 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 294 | $38,850 | $106 |
| Short return visit (20+ min) | 334 | $31,654 | $73 |
| New patient visit (45+ min) | 126 | $15,716 | $125 |
| Destruction of skin growth, 1-14 growths | 102 | $12,152 | $106 |
| Application of ultraviolet light to skin | 17 | $11,768 | $24 |
| Biopsy of related skin growth, first growth | 106 | $11,166 | $96 |
| New patient visit (30+ min) | 116 | $9,847 | $85 |
| Destruction of precancer skin growth, 15 or more growths | 39 | $8,676 | $164 |
| Destruction of precancer skin growth, 1 growth | 132 | $7,556 | $49 |
| Destruction of precancer skin growth, 2-14 growths | 108 | $3,952 | $7 |
| Application of light to destroy precancer skin growth | 18 | $3,848 | $133 |
| Short return visit | 45 | $2,211 | $43 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,204 | $138 |
| Punch biopsy, first skin growth | 15 | $1,927 | $128 |
| New patient visit (15+ min) | 34 | $1,905 | $56 |
| Biopsy of related skin growth, each additional growth | 22 | $1,288 | $52 |
2022: 18 services
| Return visit (30+ min) | 342 | $41,772 | $102 |
| Short return visit (20+ min) | 397 | $34,424 | $70 |
| Destruction of skin growth, 1-14 growths | 156 | $17,255 | $103 |
| New patient visit (45+ min) | 145 | $17,079 | $118 |
| Application of ultraviolet light to skin | 12 | $10,516 | $24 |
| Biopsy of related skin growth, first growth | 99 | $9,629 | $87 |
| Destruction of precancer skin growth, 15 or more growths | 49 | $9,301 | $158 |
| Destruction of precancer skin growth, 1 growth | 164 | $8,904 | $47 |
| New patient visit (30+ min) | 106 | $8,461 | $80 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 15 | $7,152 | None |
| Destruction of precancer skin growth, 2-14 growths | 118 | $4,812 | $7 |
| Application of light by qualified health care professional to destroy precancer skin growth | 11 | $4,191 | $233 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 11 | $3,113 | $283 |
| Punch biopsy, first skin growth | 18 | $2,487 | $124 |
| Short return visit | 49 | $2,221 | $41 |
| Application of light to destroy precancer skin growth | 12 | $2,046 | $157 |
| New patient visit (15+ min) | 33 | $1,693 | $51 |
| Biopsy of related skin growth, each additional growth | 14 | $963 | $51 |
2021: 17 services
| Return visit (30+ min) | 264 | $32,833 | $106 |
| Short return visit (20+ min) | 331 | $30,280 | $71 |
| New patient visit (45+ min) | 123 | $17,464 | $142 |
| Destruction of skin growth, 1-14 growths | 141 | $16,946 | $109 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 15 | $16,628 | None |
| Application of ultraviolet light to skin | 24 | $14,537 | $24 |
| New patient visit (30+ min) | 127 | $11,663 | $92 |
| Application of light by qualified health care professional to destroy precancer skin growth | 13 | $9,196 | $242 |
| Biopsy of related skin growth, first growth | 83 | $8,851 | $95 |
| Destruction of precancer skin growth, 1 growth | 131 | $7,256 | $48 |
| Destruction of precancer skin growth, 15 or more growths | 37 | $6,762 | $157 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $4,418 | $316 |
| Destruction of precancer skin growth, 2-14 growths | 98 | $3,745 | $7 |
| Punch biopsy, first skin growth | 15 | $2,028 | $135 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $2,007 | $154 |
| Short return visit | 37 | $1,808 | $46 |
| New patient visit (15+ min) | 17 | $828 | $49 |
2020: 16 services
| Return visit (30+ min) | 264 | $29,305 | $89 |
| Short return visit (20+ min) | 238 | $20,476 | $62 |
| Destruction of skin growth, 1-14 growths | 126 | $16,538 | $107 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 22 | $15,366 | None |
| New patient visit (30+ min) | 136 | $11,164 | $82 |
| Application of ultraviolet light to skin | 18 | $9,235 | $23 |
| Biopsy of related skin growth, first growth | 84 | $8,181 | $83 |
| Application of light by qualified health care professional to destroy precancer skin growth | 19 | $7,958 | $221 |
| Destruction of precancer skin growth, 15 or more growths | 36 | $6,488 | $144 |
| Destruction of precancer skin growth, 1 growth | 102 | $5,872 | $49 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $4,803 | $283 |
| Destruction of precancer skin growth, 2-14 growths | 71 | $2,265 | $6 |
| Punch biopsy, first skin growth | 17 | $2,170 | $128 |
| New patient visit (15+ min) | 35 | $2,160 | $62 |
| Biopsy of related skin growth, each additional growth | 15 | $1,253 | $54 |
| Short return visit | 13 | $448 | $34 |
2019: 17 services
| Return visit (30+ min) | 280 | $31,575 | $90 |
| Destruction of skin growth, 1-14 growths | 180 | $22,898 | $104 |
| Short return visit (20+ min) | 276 | $22,426 | $61 |
| New patient visit (30+ min) | 190 | $16,589 | $87 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 11 | $13,455 | $166 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 19 | $12,452 | None |
| Application of ultraviolet light to skin | 20 | $11,868 | $22 |
| Destruction of precancer skin growth, 15 or more growths | 43 | $7,158 | $143 |
| Biopsy of related skin growth, first growth | 74 | $7,120 | $86 |
| Application of light by qualified health care professional to destroy precancer skin growth | 17 | $6,526 | $204 |
| Destruction of precancer skin growth, 1 growth | 119 | $6,470 | $46 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,082 | $272 |
| Destruction of precancer skin growth, 2-14 growths | 90 | $2,787 | $5 |
| Punch biopsy, first skin growth | 21 | $2,571 | $122 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,845 | $142 |
| New patient visit (15+ min) | 26 | $1,758 | $68 |
| New patient visit (10+ min) | 12 | $489 | $41 |
2018: 13 services
| Return visit (30+ min) | 262 | $27,197 | $82 |
| Short return visit (20+ min) | 267 | $19,366 | $57 |
| Destruction of skin growth, 1-14 growths | 131 | $16,800 | $102 |
| New patient visit (30+ min) | 160 | $13,362 | $84 |
| Biopsy of single growth of skin and/or tissue | 111 | $11,668 | $92 |
| Application of ultraviolet light to skin | 15 | $11,584 | $20 |
| Destruction of precancer skin growth, 1 growth | 121 | $6,206 | $47 |
| Destruction of precancer skin growth, 15 or more growths | 37 | $5,997 | $130 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $4,538 | $284 |
| Destruction of precancer skin growth, 2-14 growths | 97 | $2,708 | $5 |
| Short return visit | 16 | $731 | $38 |
| New patient visit (15+ min) | 13 | $708 | $54 |
| Biopsy of each additional growth of skin and/or tissue | 13 | $438 | $29 |
2017: 16 services
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 12 | $42,591 | $143 |
| Destruction of skin growth, 1-14 growths | 157 | $19,894 | $101 |
| Return visit (30+ min) | 206 | $19,283 | $78 |
| New patient visit (30+ min) | 201 | $16,788 | $84 |
| Short return visit (20+ min) | 230 | $16,578 | $58 |
| Biopsy of single growth of skin and/or tissue | 104 | $10,681 | $88 |
| Application of ultraviolet light to skin | 17 | $7,237 | $20 |
| Destruction of precancer skin growth, 15 or more growths | 39 | $6,553 | $134 |
| Destruction of precancer skin growth, 1 growth | 115 | $5,789 | $46 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $3,413 | $263 |
| Destruction of precancer skin growth, 2-14 growths | 91 | $2,823 | $5 |
| Destruction of skin growth, 15 or more growths | 12 | $1,517 | $126 |
| New patient visit (15+ min) | 25 | $987 | $39 |
| Biopsy of each additional growth of skin and/or tissue | 18 | $834 | $30 |
| Short return visit | 11 | $448 | $41 |
| All potassium hydroxide (koh) preparations | 13 | $75 | $6 |
2016: 16 services
| Return visit (30+ min) | 237 | $22,332 | $79 |
| Short return visit (20+ min) | 212 | $15,264 | $58 |
| Destruction of skin growth, 1-14 growths | 128 | $15,214 | $99 |
| Application of ultraviolet light to skin | 15 | $11,954 | $20 |
| New patient visit (30+ min) | 140 | $11,210 | $80 |
| Biopsy of single growth of skin and/or tissue | 93 | $8,399 | $84 |
| Destruction of precancer skin growth, 15 or more growths | 43 | $6,880 | $132 |
| Destruction of precancer skin growth, 1 growth | 101 | $5,333 | $45 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 11 | $4,973 | None |
| Destruction of precancer skin growth, 2-14 growths | 73 | $2,207 | $5 |
| Application of light to destroy precancer skin growth | 11 | $2,130 | $118 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $1,559 | $130 |
| Removal of skin tag, 1-15 skin tags | 21 | $1,394 | $58 |
| New patient visit (15+ min) | 16 | $875 | $55 |
| Biopsy of each additional growth of skin and/or tissue | 13 | $589 | $28 |
| Short return visit | 14 | $521 | $37 |
2015: 14 services
| Return visit (30+ min) | 243 | $27,290 | $88 |
| Destruction of skin growth, 1-14 growths | 138 | $17,134 | $105 |
| Short return visit (20+ min) | 191 | $15,184 | $60 |
| New patient visit (30+ min) | 173 | $15,106 | $87 |
| Biopsy of single growth of skin and/or tissue | 119 | $11,844 | $90 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 13 | $7,360 | None |
| Destruction of precancer skin growth, 15 or more growths | 38 | $7,016 | $140 |
| Destruction of precancer skin growth, 1 growth | 110 | $5,929 | $47 |
| Application of ultraviolet light to skin | 12 | $5,506 | $21 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 17 | $5,000 | $294 |
| Application of light to destroy precancer skin growth | 13 | $3,262 | $130 |
| Destruction of precancer skin growth, 2-14 growths | 88 | $2,239 | $5 |
| New patient visit (15+ min) | 28 | $1,594 | $57 |
| Biopsy of each additional growth of skin and/or tissue | 19 | $703 | $31 |
2014: 14 services
| Short return visit (20+ min) | 237 | $18,395 | $59 |
| Return visit (30+ min) | 176 | $17,254 | $83 |
| Destruction of skin growth, 1-14 growths | 134 | $15,869 | $97 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 27 | $14,516 | None |
| Biopsy of single growth of skin and/or tissue | 129 | $12,984 | $85 |
| New patient visit (30+ min) | 130 | $10,835 | $83 |
| Application of light to destroy precancer skin growth | 27 | $7,051 | $122 |
| Destruction of precancer skin growth, 1 growth | 110 | $6,855 | $52 |
| Destruction of precancer skin growth, 15 or more growths | 39 | $6,455 | $132 |
| Destruction of precancer skin growth, 2-14 growths | 85 | $4,334 | $9 |
| New patient visit (15+ min) | 31 | $1,600 | $52 |
| Biopsy of each additional growth of skin and/or tissue | 24 | $968 | $28 |
| Short return visit | 17 | $673 | $37 |
| All potassium hydroxide (koh) preparations | 12 | $74 | $6 |
2013: 16 services
| Short return visit (20+ min) | 253 | $19,589 | $57 |
| Destruction of skin growth, 1-14 growths | 90 | $10,674 | $103 |
| Biopsy of single growth of skin and/or tissue | 103 | $10,374 | $89 |
| Destruction of precancer skin growth, 15 or more growths | 44 | $7,513 | $147 |
| Application of ultraviolet light to skin | 15 | $7,198 | $21 |
| New patient visit (30+ min) | 78 | $6,653 | $85 |
| Destruction of precancer skin growth, 1 growth | 93 | $6,411 | $59 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 15 | $5,904 | None |
| New patient visit (15+ min) | 92 | $5,088 | $55 |
| Return visit (30+ min) | 48 | $5,084 | $77 |
| Application of light to destroy precancer skin growth | 15 | $3,992 | $138 |
| Destruction of precancer skin growth, 2-14 growths | 73 | $2,184 | $6 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,800 | $150 |
| Biopsy of each additional growth of skin and/or tissue | 19 | $878 | $29 |
| Short return visit | 18 | $682 | $36 |
| All potassium hydroxide (koh) preparations | 11 | $63 | $6 |
Medicaid work
$699 in 2024
Medicaid paid $699 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $699 |
| 2024 | 12 | 1 | 12 | $699 |
| 2023 | 27 | 1 | 13 | $2,249 |
| 2022 | 15 | 1 | 15 | $1,654 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 27 | $2,249 |
2022
| Return visit (30+ min) | 15 | $1,654 |
Drugs they prescribed that Part D paid
$534,416
Pharmacies billed $534,416 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,743) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,616 generic and 127 brand-name prescriptions · $534,416 in drug cost · 50 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 26 | $101,084 | $3,888 |
| Fluorouracil | 86 | $6,514 | $76 |
| Tacrolimus | 61 | $5,923 | $97 |
| Betamethasone Diprop Augmented | 293 | $5,528 | $19 |
| Metronidazole | 84 | $5,420 | $65 |
See all 30 drugs
| Dupixent | 26 | $101,084 | $3,888 |
| Fluorouracil | 86 | $6,514 | $76 |
| Tacrolimus | 61 | $5,923 | $97 |
| Betamethasone Diprop Augmented | 293 | $5,528 | $19 |
| Metronidazole | 84 | $5,420 | $65 |
| Clobetasol Propionate | 80 | $4,170 | $52 |
| Ivermectin | 11 | $3,737 | $340 |
| Fluocinonide | 75 | $3,637 | $48 |
| Azelaic Acid | 29 | $3,611 | $125 |
| Doxycycline Hyclate | 84 | $2,972 | $35 |
| Triamcinolone Acetonide | 223 | $2,339 | $10 |
| Calcipotriene | 16 | $2,048 | $128 |
| Ketoconazole | 75 | $1,760 | $23 |
| Econazole Nitrate | 47 | $1,633 | $35 |
| Fluocinolone Acetonide | 11 | $1,134 | $103 |
| Ciclopirox | 48 | $1,129 | $24 |
| Hydroxyzine | 27 | $1,111 | $41 |
| Sulfacetamide | 11 | $973 | $88 |
| Mometasone Furoate | 43 | $955 | $22 |
| Fluocinolone Acetonide | 11 | $742 | $67 |
| Hydrocortisone | 64 | $687 | $11 |
| Minoxidil | 29 | $365 | $13 |
| Ammonium Lactate | 19 | $359 | $19 |
| Ssd | 13 | $301 | $23 |
| Minocycline | 12 | $252 | $21 |
| Nystatin | 15 | $190 | $13 |
| Imiquimod | 12 | $173 | $14 |
| Terbinafine | 17 | $101 | $6 |
| Valacyclovir | 16 | $92 | $6 |
| Mupirocin | 13 | $91 | $7 |
Year by year
| 2024 | 1,743 | 608 | 0% (0) | 7% | $534,416 |
| 2023 | 1,606 | 540 | 0% (0) | 7% | $471,955 |
| 2022 | 1,583 | 580 | 0% (0) | 8% | $469,583 |
| 2021 | 1,141 | 468 | 0% (0) | 6% | $151,549 |
| 2020 | 859 | 365 | 0% (0) | 10% | $140,551 |
| 2019 | 948 | 382 | 0% (0) | 9% | $138,659 |
| 2018 | 798 | 305 | 0% (0) | 13% | $164,888 |
| 2017 | 762 | 317 | 0% (0) | 14% | $121,352 |
| 2016 | 694 | 261 | 0% (0) | 19% | $124,053 |
| 2015 | 783 | 279 | 0% (0) | None | $110,520 |
| 2014 | 662 | 240 | None | 18% | $54,828 |
| 2013 | 618 | 227 | 0% (0) | None | $56,296 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Dupixent | 14 | $55,763 | $3,983 |
| Dupixent | 13 | $53,829 | $4,141 |
| Tacrolimus | 49 | $11,875 | $242 |
| Fluorouracil | 77 | $9,139 | $119 |
| Pimecrolimus | 23 | $5,816 | $253 |
| Metronidazole | 74 | $5,335 | $72 |
| Betamethasone Diprop Augmented | 238 | $4,796 | $20 |
| Fluocinonide | 67 | $3,995 | $60 |
| Azelaic Acid | 29 | $3,848 | $133 |
| Clobetasol Propionate | 56 | $3,791 | $68 |
| Doxycycline Hyclate | 96 | $3,693 | $38 |
| Triamcinolone Acetonide | 253 | $3,685 | $15 |
| Tazarotene | 22 | $3,097 | $141 |
| Ketoconazole | 71 | $2,368 | $33 |
| Desonide | 23 | $2,225 | $97 |
| Econazole Nitrate | 44 | $2,197 | $50 |
| Sulfacetamide | 11 | $1,320 | $120 |
| Ciclopirox | 26 | $1,095 | $42 |
| Mometasone Furoate | 29 | $912 | $31 |
| Fluocinolone Acetonide | 14 | $762 | $54 |
| Desoximetasone | 13 | $708 | $54 |
| Clindamycin Phosphate | 14 | $692 | $49 |
| Hydrocortisone | 47 | $656 | $14 |
| Hydroxyzine | 15 | $567 | $38 |
| Ammonium Lactate | 16 | $433 | $27 |
| Nystatin | 14 | $406 | $29 |
| Minocycline | 12 | $175 | $15 |
| Mupirocin | 14 | $138 | $10 |
| Valacyclovir | 13 | $132 | $10 |
| Prednisone | 12 | $77 | $6 |
| Cephalexin | 13 | $67 | $5 |
2022: 21 drugs
| Dupixent | 15 | $55,096 | $3,673 |
| Fluorouracil | 85 | $13,018 | $153 |
| Tacrolimus | 52 | $8,984 | $173 |
| Fluocinonide | 113 | $6,763 | $60 |
| Betamethasone Diprop Augmented | 208 | $6,414 | $31 |
| Metronidazole | 67 | $5,318 | $79 |
| Triamcinolone Acetonide | 333 | $4,639 | $14 |
| Econazole Nitrate | 38 | $4,423 | $116 |
| Clobetasol Propionate | 43 | $3,850 | $90 |
| Pimecrolimus | 14 | $3,668 | $262 |
| Ketoconazole | 71 | $3,106 | $44 |
| Azelaic Acid | 22 | $2,641 | $120 |
| Doxycycline Hyclate | 79 | $2,539 | $32 |
| Sulfacetamide | 23 | $2,114 | $92 |
| Mometasone Furoate | 49 | $1,686 | $34 |
| Fluocinolone Acetonide | 14 | $1,112 | $79 |
| Ciclopirox | 21 | $1,069 | $51 |
| Desoximetasone | 15 | $743 | $50 |
| Hydroxyzine | 21 | $542 | $26 |
| Hydrocortisone | 28 | $515 | $18 |
| Mupirocin | 28 | $450 | $16 |
2021: 20 drugs
| Metronidazole | 61 | $5,308 | $87 |
| Clobetasol Propionate | 58 | $5,280 | $91 |
| Pimecrolimus | 16 | $4,992 | $312 |
| Fluorouracil | 39 | $4,863 | $125 |
| Fluocinonide | 72 | $4,442 | $62 |
| Tacrolimus | 31 | $4,274 | $138 |
| Betamethasone Diprop Augmented | 170 | $3,859 | $23 |
| Triamcinolone Acetonide | 262 | $3,238 | $12 |
| Halobetasol Propionate | 21 | $2,492 | $119 |
| Ketoconazole | 57 | $2,335 | $41 |
| Fluocinolone Acetonide | 15 | $1,528 | $102 |
| Mometasone Furoate | 45 | $1,255 | $28 |
| Doxycycline Hyclate | 39 | $1,097 | $28 |
| Desonide | 12 | $708 | $59 |
| Econazole Nitrate | 15 | $442 | $29 |
| Ciclopirox | 15 | $404 | $27 |
| Nystatin | 12 | $260 | $22 |
| Hydrocortisone | 20 | $224 | $11 |
| Mupirocin | 17 | $164 | $10 |
| Hydroxyzine | 14 | $142 | $10 |
2020: 20 drugs
| Metronidazole | 44 | $6,971 | $158 |
| Tacrolimus | 21 | $5,776 | $275 |
| Finacea | 11 | $3,844 | $349 |
| Pimecrolimus | 14 | $3,497 | $250 |
| Clobetasol Propionate | 36 | $3,464 | $96 |
| Betamethasone Diprop Augmented | 128 | $2,751 | $21 |
| Doxepin | 16 | $2,392 | $150 |
| Fluocinolone Acetonide | 17 | $2,304 | $136 |
| Fluorouracil | 17 | $2,261 | $133 |
| Fluocinonide | 46 | $2,194 | $48 |
| Ketoconazole | 40 | $1,982 | $50 |
| Triamcinolone Acetonide | 159 | $1,723 | $11 |
| Mometasone Furoate | 40 | $1,083 | $27 |
| Doxycycline Hyclate | 22 | $1,062 | $48 |
| Nystatin | 33 | $918 | $28 |
| Hydrocortisone | 32 | $605 | $19 |
| Desonide | 13 | $459 | $35 |
| Econazole Nitrate | 11 | $440 | $40 |
| Ciclopirox | 12 | $303 | $25 |
| Mupirocin | 14 | $99 | $7 |
2019: 20 drugs
| Doxepin | 18 | $7,382 | $410 |
| Metronidazole | 41 | $5,885 | $144 |
| Tacrolimus | 27 | $5,195 | $192 |
| Fluocinonide | 67 | $4,798 | $72 |
| Clobetasol Propionate | 47 | $4,632 | $99 |
| Betamethasone Diprop Augmented | 138 | $2,803 | $20 |
| Fluorouracil | 15 | $2,270 | $151 |
| Doxycycline Hyclate | 38 | $2,216 | $58 |
| Triamcinolone Acetonide | 175 | $2,113 | $12 |
| Mometasone Furoate | 50 | $1,477 | $30 |
| Ketoconazole | 25 | $1,201 | $48 |
| Econazole Nitrate | 17 | $1,089 | $64 |
| Nystatin | 20 | $758 | $38 |
| Betamethasone Dipropionate | 14 | $489 | $35 |
| Hydrocortisone | 36 | $473 | $13 |
| Valacyclovir | 16 | $396 | $25 |
| Clindamycin Phosphate | 14 | $390 | $28 |
| Ciclopirox | 15 | $385 | $26 |
| Hydroxyzine | 17 | $181 | $11 |
| Terbinafine | 12 | $70 | $6 |
2018: 17 drugs
| Fluocinonide | 89 | $8,523 | $96 |
| Doxepin | 15 | $7,181 | $479 |
| Clobetasol Propionate | 47 | $5,817 | $124 |
| Econazole Nitrate | 22 | $2,949 | $134 |
| Betamethasone Diprop Augmented | 83 | $2,731 | $33 |
| Metronidazole | 23 | $2,334 | $101 |
| Triamcinolone Acetonide | 146 | $1,839 | $13 |
| Sulfacetamide | 12 | $1,728 | $144 |
| Ketoconazole | 28 | $1,446 | $52 |
| Imiquimod | 11 | $1,440 | $131 |
| Doxycycline Hyclate | 22 | $827 | $38 |
| Hydrocortisone | 49 | $745 | $15 |
| Alclometasone Dipropionate | 12 | $744 | $62 |
| Valacyclovir | 21 | $716 | $34 |
| Clindamycin Phosphate | 11 | $688 | $63 |
| Mometasone Furoate | 21 | $586 | $28 |
| Betamethasone Dipropionate | 14 | $425 | $30 |
2017: 15 drugs
| Clobetasol Propionate | 68 | $11,151 | $164 |
| Fluocinonide | 106 | $10,036 | $95 |
| Elidel | 13 | $9,438 | $726 |
| Doxycycline Ir-Dr | 13 | $7,432 | $572 |
| Doxepin | 16 | $5,090 | $318 |
| Metronidazole | 33 | $3,501 | $106 |
| Triamcinolone Acetonide | 144 | $2,308 | $16 |
| Betamethasone Dipropionate | 36 | $1,943 | $54 |
| Doxycycline Hyclate | 22 | $1,291 | $59 |
| Ketoconazole | 15 | $989 | $66 |
| Hydrocortisone | 56 | $979 | $17 |
| Mometasone Furoate | 25 | $935 | $37 |
| Ciclopirox | 20 | $655 | $33 |
| Doxycycline Monohydrate | 14 | $259 | $19 |
| Valacyclovir | 12 | $70 | $6 |
2016: 15 drugs
| Elidel | 17 | $18,010 | $1,059 |
| Clobetasol Propionate | 110 | $17,258 | $157 |
| Fluocinonide | 87 | $7,895 | $91 |
| Doxycycline Ir-Dr | 11 | $5,973 | $543 |
| Desonide | 29 | $4,552 | $157 |
| Metronidazole | 29 | $3,480 | $120 |
| Econazole Nitrate | 15 | $2,791 | $186 |
| Triamcinolone Acetonide | 121 | $2,012 | $17 |
| Desoximetasone | 25 | $1,709 | $68 |
| Doxycycline Hyclate | 22 | $1,246 | $57 |
| Betamethasone Dipropionate | 14 | $1,090 | $78 |
| Ketoconazole | 12 | $556 | $46 |
| Hydrocortisone | 48 | $545 | $11 |
| Mometasone Furoate | 13 | $514 | $40 |
| Ciclopirox | 13 | $422 | $32 |
2015: 18 drugs
| Clobetasol Propionate | 124 | $31,061 | $250 |
| Elidel | 13 | $12,254 | $943 |
| Desonide | 27 | $7,871 | $292 |
| Fluocinonide | 63 | $6,389 | $101 |
| Tazorac | 12 | $3,436 | $286 |
| Triamcinolone Acetonide | 149 | $2,269 | $15 |
| Metronidazole | 18 | $2,170 | $121 |
| Desoximetasone | 15 | $1,577 | $105 |
| Betamethasone Valerate | 19 | $1,481 | $78 |
| Doxycycline Hyclate | 22 | $1,465 | $67 |
| Ciclopirox | 24 | $1,339 | $56 |
| Betamethasone Dipropionate | 16 | $1,151 | $72 |
| Hydrocortisone | 74 | $1,097 | $15 |
| Ketoconazole | 28 | $941 | $34 |
| Clindamycin Phosphate | 12 | $806 | $67 |
| Proctosol-Hc | 11 | $497 | $45 |
| Mometasone Furoate | 14 | $478 | $34 |
| Ammonium Lactate | 12 | $362 | $30 |
2014: 16 drugs
| Desonide | 35 | $9,982 | $285 |
| Fluocinonide | 78 | $4,489 | $58 |
| Clobetasol Propionate | 59 | $3,877 | $66 |
| Doxycycline Hyclate | 29 | $3,370 | $116 |
| Metronidazole | 16 | $1,774 | $111 |
| Triamcinolone Acetonide | 66 | $1,337 | $20 |
| Betamethasone Valerate | 22 | $1,168 | $53 |
| Hydrocortisone | 67 | $978 | $15 |
| Proctosol-Hc | 27 | $911 | $34 |
| Ciclopirox | 17 | $767 | $45 |
| Mometasone Furoate | 24 | $764 | $32 |
| Betamethasone Dipropionate | 16 | $593 | $37 |
| Econazole Nitrate | 14 | $567 | $41 |
| Ketoconazole | 20 | $540 | $27 |
| Ammonium Lactate | 11 | $262 | $24 |
| Cephalexin | 13 | $100 | $8 |
2013: 11 drugs
| Desonide | 53 | $9,860 | $186 |
| Fluocinonide | 91 | $4,643 | $51 |
| Clobetasol Propionate | 70 | $3,671 | $52 |
| Fluorouracil | 12 | $2,353 | $196 |
| Doxycycline Hyclate | 15 | $1,687 | $112 |
| Betamethasone Dipropionate | 22 | $1,237 | $56 |
| Triamcinolone Acetonide | 68 | $1,125 | $17 |
| Hydrocortisone | 47 | $972 | $21 |
| Mometasone Furoate | 19 | $711 | $37 |
| Ketoconazole | 18 | $449 | $25 |
| Ciclopirox | 17 | $418 | $25 |
Money from drug and device companies
$280 in 2025
| 2025 | 3 | 3 | None | $280 |
| 2024 | 1 | 1 | None | $125 |
| 2023 | 2 | 2 | None | $139 |
| 2019 | 1 | 2 | None | $33 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | Nemluvio | $149 | 1 payment
|
| Lilly USA | Ebglyss | $116 | 1 payment
|
| Pfizer | Cibinqo | $15 | 1 payment
|
See all 3 published payments
| Lilly USA | Meals · 2025-11-13 | Ebglyss | $116 |
| Pfizer | Education · 2025-02-26 | Cibinqo | $15 |
| Galderma Laboratories L.P. | Meals · 2025-01-08 | Nemluvio | $149 |
See earlier years (2024, 2023, 2019)
2024: $125
| Lilly USA | None | $125 | 1 payment
|
2023: $139
| Lilly USA | Olumiant | $124 | 1 payment
|
| Pfizer | Cibinqo | $15 | 1 payment
|
2019: $33
| Allergan | Botox Cosmetic | $33 | 2 payments
|
Professional record
- NPI
- 1841386489
- Licence
- CA A88967California A88967: Current · expires 2028-07-31
- Trained
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 2003
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-10-04
- NPI last updated
- 2020-06-04
- NPI record certified
- 2020-06-04
This is when the NPI record was last certified, not a medical board exam.